 Massimo Buvoli
Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myosin Heavy Chains | 7 | 2021 | 178 | 1.260 |
Why?
| | Gene Transfer Techniques | 4 | 2007 | 147 | 0.660 |
Why?
| | Cardiac Myosins | 4 | 2016 | 26 | 0.640 |
Why?
| | Distal Myopathies | 2 | 2016 | 6 | 0.530 |
Why?
| | Proline | 2 | 2016 | 72 | 0.500 |
Why?
| | Mutation | 4 | 2011 | 3338 | 0.450 |
Why?
| | Myocardium | 4 | 2021 | 911 | 0.410 |
Why?
| | Sarcomeres | 2 | 2015 | 90 | 0.410 |
Why?
| | Exons | 4 | 2010 | 301 | 0.400 |
Why?
| | RNA, Transfer | 3 | 2003 | 118 | 0.390 |
Why?
| | Myocytes, Cardiac | 3 | 2021 | 449 | 0.370 |
Why?
| | RNA Splicing | 3 | 2007 | 244 | 0.330 |
Why?
| | Muscular Dystrophy, Animal | 2 | 2007 | 8 | 0.320 |
Why?
| | Adenoviridae | 3 | 2007 | 184 | 0.290 |
Why?
| | Cardiomyopathies | 3 | 2021 | 298 | 0.270 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2007 | 82 | 0.270 |
Why?
| | Codon, Terminator | 2 | 2002 | 21 | 0.240 |
Why?
| | Computational Biology | 1 | 2008 | 528 | 0.230 |
Why?
| | Genetic Vectors | 2 | 2002 | 287 | 0.220 |
Why?
| | RNA, Messenger | 5 | 2021 | 2550 | 0.220 |
Why?
| | Genomics | 1 | 2008 | 631 | 0.220 |
Why?
| | Myosin Type II | 1 | 2021 | 10 | 0.190 |
Why?
| | Heart Ventricles | 2 | 2021 | 723 | 0.180 |
Why?
| | Ventricular Myosins | 2 | 2012 | 33 | 0.180 |
Why?
| | Suppression, Genetic | 1 | 2000 | 23 | 0.180 |
Why?
| | COS Cells | 3 | 2016 | 175 | 0.170 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2019 | 18 | 0.170 |
Why?
| | Myocardial Contraction | 1 | 2021 | 318 | 0.170 |
Why?
| | MicroRNAs | 2 | 2019 | 600 | 0.160 |
Why?
| | Promoter Regions, Genetic | 2 | 2002 | 1131 | 0.160 |
Why?
| | Myoblasts | 1 | 2019 | 76 | 0.160 |
Why?
| | Heart | 1 | 2003 | 613 | 0.160 |
Why?
| | Mice | 10 | 2021 | 14843 | 0.150 |
Why?
| | Animals | 16 | 2021 | 31565 | 0.150 |
Why?
| | Myosin Subfragments | 2 | 2015 | 22 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2002 | 1310 | 0.150 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2783 | 0.140 |
Why?
| | Rats | 5 | 2021 | 4913 | 0.140 |
Why?
| | DNA | 5 | 2016 | 1350 | 0.140 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 3 | 1993 | 8 | 0.130 |
Why?
| | Contracture | 1 | 2016 | 23 | 0.130 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2019 | 350 | 0.130 |
Why?
| | Ribonucleoproteins | 3 | 1993 | 85 | 0.130 |
Why?
| | Protein Structure, Secondary | 2 | 2015 | 325 | 0.120 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2182 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2629 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2322 | 0.110 |
Why?
| | RNA, Heterogeneous Nuclear | 2 | 1993 | 4 | 0.110 |
Why?
| | Alternative Splicing | 2 | 2010 | 186 | 0.110 |
Why?
| | Cell Differentiation | 2 | 2019 | 1696 | 0.110 |
Why?
| | Genes | 2 | 1990 | 223 | 0.100 |
Why?
| | Transfection | 3 | 2012 | 863 | 0.100 |
Why?
| | Cells, Cultured | 4 | 2007 | 3861 | 0.100 |
Why?
| | Enhancer Elements, Genetic | 2 | 2007 | 151 | 0.100 |
Why?
| | Amino Acids | 1 | 2015 | 445 | 0.100 |
Why?
| | Genes, Reporter | 2 | 2003 | 256 | 0.100 |
Why?
| | Base Sequence | 6 | 2007 | 2114 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 38 | 0.090 |
Why?
| | Animals, Genetically Modified | 1 | 2011 | 215 | 0.090 |
Why?
| | Plasmids | 2 | 2003 | 343 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 796 | 0.080 |
Why?
| | Introns | 1 | 2010 | 227 | 0.080 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 1981 | 0.080 |
Why?
| | Protein Isoforms | 1 | 2010 | 337 | 0.080 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 268 | 0.080 |
Why?
| | Muscular Diseases | 1 | 2008 | 104 | 0.070 |
Why?
| | Dystrophin | 1 | 2007 | 30 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2008 | 373 | 0.070 |
Why?
| | Polylysine | 1 | 2007 | 17 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2008 | 206 | 0.070 |
Why?
| | Hypertrophy | 1 | 2007 | 109 | 0.070 |
Why?
| | Oligonucleotide Probes | 2 | 2000 | 54 | 0.070 |
Why?
| | Protein Conformation | 1 | 2008 | 803 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2019 | 1947 | 0.060 |
Why?
| | Animals, Newborn | 1 | 2007 | 777 | 0.060 |
Why?
| | Blotting, Western | 2 | 2021 | 1143 | 0.060 |
Why?
| | Amino Acid Substitution | 2 | 2016 | 261 | 0.050 |
Why?
| | Mutant Proteins | 2 | 2015 | 95 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2090 | 0.050 |
Why?
| | Genetic Therapy | 2 | 2002 | 256 | 0.050 |
Why?
| | Molecular Biology | 1 | 2003 | 56 | 0.050 |
Why?
| | Humans | 14 | 2021 | 114045 | 0.050 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2000 | 138 | 0.050 |
Why?
| | Gene Targeting | 1 | 2002 | 75 | 0.050 |
Why?
| | Luciferases | 1 | 2002 | 142 | 0.050 |
Why?
| | Nucleic Acid Hybridization | 2 | 2000 | 187 | 0.050 |
Why?
| | Transgenes | 1 | 2002 | 170 | 0.050 |
Why?
| | RNA | 2 | 2021 | 806 | 0.050 |
Why?
| | RNA, Transfer, Ser | 1 | 2000 | 4 | 0.040 |
Why?
| | Blotting, Northern | 1 | 2000 | 193 | 0.040 |
Why?
| | Cadaver | 1 | 2021 | 298 | 0.040 |
Why?
| | Myogenin | 1 | 2019 | 12 | 0.040 |
Why?
| | Tongue | 1 | 2000 | 66 | 0.040 |
Why?
| | Mammals | 1 | 2021 | 241 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2016 | 1468 | 0.040 |
Why?
| | Tropomyosin | 1 | 1998 | 13 | 0.040 |
Why?
| | Cardiovascular Diseases | 2 | 2002 | 1726 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 594 | 0.040 |
Why?
| | Back | 1 | 2016 | 10 | 0.030 |
Why?
| | Heterogeneous Nuclear Ribonucleoprotein A1 | 3 | 1993 | 4 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 3 | 1993 | 18 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 4680 | 0.030 |
Why?
| | Neck | 1 | 2016 | 85 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 250 | 0.030 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2015 | 16 | 0.030 |
Why?
| | Pliability | 1 | 2015 | 45 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2015 | 166 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 156 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 1998 | 344 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3498 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2015 | 499 | 0.030 |
Why?
| | HeLa Cells | 2 | 1998 | 563 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2015 | 200 | 0.030 |
Why?
| | Models, Biological | 1 | 2000 | 1611 | 0.030 |
Why?
| | Electrochemistry | 1 | 2012 | 79 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2012 | 94 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2012 | 81 | 0.020 |
Why?
| | Gene Expression | 1 | 1997 | 1417 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2012 | 345 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2012 | 157 | 0.020 |
Why?
| | SOXD Transcription Factors | 1 | 2010 | 5 | 0.020 |
Why?
| | Poly A | 1 | 1990 | 45 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2010 | 37 | 0.020 |
Why?
| | Light | 1 | 2012 | 336 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 1990 | 155 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 613 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2010 | 285 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 323 | 0.020 |
Why?
| | Male | 3 | 2019 | 55396 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 1880 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1990 | 522 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 2784 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 1990 | 386 | 0.020 |
Why?
| | Escherichia coli | 1 | 1990 | 723 | 0.020 |
Why?
| | Zebrafish | 1 | 2010 | 413 | 0.020 |
Why?
| | Female | 2 | 2019 | 59324 | 0.010 |
Why?
| | Restriction Mapping | 2 | 1993 | 77 | 0.010 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2000 | 16 | 0.010 |
Why?
| | Aged | 1 | 2016 | 18969 | 0.010 |
Why?
| | Binding Sites | 2 | 1993 | 1166 | 0.010 |
Why?
| | Mice, Inbred mdx | 1 | 1997 | 11 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2000 | 670 | 0.010 |
Why?
| | Adult | 1 | 2016 | 30375 | 0.010 |
Why?
| | Growth Substances | 1 | 1993 | 138 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 155 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1997 | 926 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1993 | 225 | 0.010 |
Why?
| | Cell Division | 1 | 1993 | 754 | 0.010 |
Why?
| | Transcription Factors | 1 | 1993 | 1526 | 0.000 |
Why?
|
|
Buvoli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|